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ABSTRACT
This report presents an approach to predict pancreatic cancer using Support Vector Machine Classification
algorithm. The research objective of this project it to predict pancreatic cancer on just genomic, just clinical and
combination of genomic and clinical data. We have used real genomic data having 22,763 samples and 154
features per sample. We have also created Synthetic Clinical data having 400 samples and 7 features per sample
in order to predict accuracy of just clinical data. To validate the hypothesis, we have combined synthetic clinical
data with subset of features from real genomic data. In our results, we observed that prediction accuracy,
precision, recall with just genomic data is 80.77%, 20%, 4%. Prediction accuracy, precision, recall with just
synthetic clinical data is 93.33%, 95%, 30%. While prediction accuracy, precision, recall for combination of
real genomic and synthetic clinical data is 90.83%, 10%, 5%. The combination of real genomic and synthetic
clinical data decreased the accuracy since the genomic data is weakly correlated. Thus we conclude that the
combination of genomic and clinical data does not improve pancreatic cancer prediction accuracy. A dataset
with more significant genomic features might help to predict pancreatic cancer more accurately.
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1. INTRODUCTION
Pancreatic Cancer is an ailment in which harmful cells shape in the tissues of the pancreas. Cells in the
body begin to grow uncontrollably. Pancreas is located behind the stomach and produce hormones
that control sugar. Most of pancreatic cancers commence in the cells that produce these hormones
[Journal of Clinical Oncology and Research, 2014].
Different cancers have different symptoms. But having a symptom, or even several symptoms, does not
mean that one will get the disease. Few of the Clinical symptoms for Pancreatic Cancer are Jaundice,
Floating Bowels, Unintentional Weight Loss, Smoking, Family History of Cancer while genomic symptoms
are gene mutation in following genes: KRAS, TP53, CDKN2A, SMAD4, genetic gain in chromosome 8q,
genetic loss in chromosome 9p, presence of genes MLL315, ATM15, KDM6A12 because of structural
variations and gene mutation.
Prostate cancer is a common and frequent cause of cancer death. In the United States, prostate cancer is the
most commonly diagnosed visceral cancer; in 2016, there are expected to be approximately 181,000 new
prostate cancer diagnoses and approximately 26,100 prostate cancer deaths [e.Siegel RL, Cancer statistics,
2016. - PubMed - NCBI"]. Prostate cancer is second only to skin cancer and lung cancer as the leading
cause of cancer and cancer death, respectively, in United States men. Worldwide, in 2012 there were
estimated to be 1,112,000 new cases of prostate cancer and 308,000 prostate cancer deaths, making it the
second most commonly diagnosed cancer in men and the fifth leading cause of male cancer death [e.Torre
LA, Global cancer statistics, 2012].
The mortality rate of pancreatic cancer patients is approaching 100%. Only 4% of the patients survive 5
years or more after being diagnosed. All these grim statistics of pancreatic cancer necessitates the urgent
development of methods to facilitate their early detection and prevention [AB, et al, 2004]. Despite the
advancement of knowledge in recent years regarding the pathophysiology of pancreatic cancer [D, et al,
2004] [M, et al, 2004], there is no effective method to diagnose this cancer type early enough to impact the
treatment outcomes.

Prostate Cancer is a very complex disease, and the decision-making process is challenging because it
requires a fine balance among expected clinical benefit, life expectancy and potential treatment-related
adverse events [A, et al, 2009]. The prediction of clinical outcomes is therefore critical. Accurate estimates
of stage and of the likelihood of cancer diagnosis, clinical significance, treatment success, and complications
are important for patient counseling and informed decision-making. By understanding the most probable
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endpoint of a patient’s clinical course, physicians may modify treatment and post-treatment strategies in
order balance benefits and adverse events of treatment. Prediction also allows patients to choose responsibly
among the different treatment strategies proposed by the clinicians. Properly informing the patient of these
likelihoods could improve the patient’s satisfaction after treatment [Shariat, 2009]. Thus early prediction of
Prostate Cancer will help reduce its mortality.

2. LITERATURE REVIEW
2.1 Towards Prediction of Pancreatic Cancer Using SVM Study Model:
Goal of this paper is to Predict Pancreatic Cancer using Support Vector Machine. Some studies [CK, et al,
1982] [Riboli E, et al, 1983] indicate that tumor variation is a strong symptom of pancreatic cancer. This
suggests that histological tumor differentiation and lymph node metastasis could be a good predictor for
pancreatic cancer. Thus this work aims at evaluating following biological properties and provide predictive
information of cancer cell behavior pre-operatively: “Lymph node metastasis” and “Tumor metastasis” in
Pancreatic Cancer. This work makes use of accumulated leftover laboratory data which involves many
features. The clinical tests are considered as an n-dimensional pathological feature set, where n refers to the
number of clinical tests. By taking the n samples and grouping them by a particular status, this data is used
to train a classifier, which can then be assessed by the cross-validation technique.

Dataset
In this study, 174 surgically resected and histologically confirmed common type pancreatic cancer cases at
the National Cancer Center Hospital in Japan are utilized for the analysis. Tumor differentiation status and
lymph node metastatic status (N0; negative nodal metastasis or N+; positive nodal metastasis), are used as
the basis of classification.
Following two data sets are prepared based on the above classification criteria: Set Diff (tumor
differentiation between poorly differentiated vs. others) and the Set N1 (N+ vs. N0). For Set Diff, poorly to
moderately differentiated tumor samples are considered as positive samples, well differentiated tumor
samples are taken as negative samples. For Set N1, N0 are defined as negative findings while the rest as
positive, with a total of 86 positive samples. Following clinical laboratory data from the same cancer cases is
also used: CEA, CA19-9, Glucose, Elastase I, Serum Amylase, C-reactive protein (CRP), Serum Glucose
(GLU), Fibrin degradation product (FDP), Fibrinogen (FIBG) and Antithrombin III (ATIII). We also use
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data regarding age, sex, tumor location, tumor size (TS mm), number of lymphocytes (LymphNum) and
lymphocyte ratio (LymphCell).

Methodology
To identify important features, feature ranking is done using several available feature selection criteria like
“entropy”, “t-test”, “ROC”, “bhattacharyya” After feature ranking, “FIBG”, “CA19-9”, “CEA” and
“Elastase I” are selected as top four features. All the features used for analysis are initially converted into
several groups: “low”, “normal” and “high” based on the definition of the normal ranges provided by
National Cancer Center Hospital described in detail in [12]. In order to quantize the features, numbers -1, 0
and 1 are used to indicate low group, normal range and high group respectively. As a result, 59 data
instances are used to train the SVM. Integrating the four significant features, a data set of size 59-by-4 (59
patients and 4 features) is created.

Results and Discussion
Classification performance of the model used in this paper is compared with other Machine Learning
techniques like Decision Trees (DT) and K Nearest Neighborhood (KNN). The accuracy of SVM is 70%
which is better than DT (65%) and KNN (69%). Average Specificity of SVM is 70% which is slightly less
than DT (79%) and KNN (99%). Average Sensitivity is 70% which shows that this model is very good in
predictions. AUC values are compared to find out how effective the models are. The proposed model was
employed to predict new pancreatic cancer samples and the accuracy of this experiment was 72% which is
quite remarkable. Thus the approaches used for feature selection and outlier detection help in classifying
correctly.

2.2 Machine learning of clinical performance in a pancreatic cancer database:
Approach
The majority of predictive models in modern oncology literature are generated by regression algorithms,
particularly linear regression, logistic regression, and Cox’s proportional hazard model [Y, et al, 2003] [R, et
al, 2002] [JF, 2004]. Author has used both the traditional algorithms (linear and logistic regression), and
machine learning classification algorithms (Bayesian nets, decision trees, k -nearest-neighbor, neural
networks, among others) to generate prediction models. A clinical database consisting of 91 patient
treatments over the course of several years was constructed. The accuracies of machine learning prediction
models were statistically compared to those generated by traditional methods over this clinical database. Set
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of prediction target attributes for which to develop prediction models were selected which include tumor
size, T-staging, N-staging, vasculature involvement, tumor histology, malignancy, survival rates, and ECOG
scores at 6-month, 9-month, and 12-month follow-up intervals. For each of these target attributes,
performance of the prediction algorithms was tested on a data set extracted from the clinical database by
removing the value of the selected target attribute from each patient treatment instance. Predicted values of
the target attribute based on the remaining attributes were compared with the value of the target attribute in
the full database.

Dataset
Pancreatic cancer patients seen over a three-year period at the Dept. of Surgical Oncology at the University
of Massachusetts Memorial Hospital in Worcester, MA were considered. Complete screening, treatment,
and follow-up records were retrospectively compiled from the hospital’s Meditech electronic record system
into this clinical database. Supervision by the medical staff was provided for the interpretation of ambiguous
or incomplete records. A total of 91 evaluations for pancreatic cancer treatment were done between April
2003 and May 2006, representing 87 unique patients. Among the patients, 49 (56%) were female. Among
the tumors evaluated, 75 (82%) were deemed potentially resectable, 7 (8%) locally advanced/unresectable,
and 9 (10%) metastatic or equivocal. A total of 74 (81%) resections were subsequently performed with a
surgical success rate (complete excision of tumor) of 96%. Radiotherapy was assigned in 37 (41%)
evaluations, chemotherapy in 39 (43%) evaluations, and palliative measures in 11 (12%) evaluations. One of
the challenges with the data set was a relatively small number (91) of patient instances were available for
this study. Studies are often constrained by the number of patients seen at an institution, or the rarity of
certain disease etiologies [M, et al, 1997]. The number of patients available in this study has proved
sufficient in other pancreatic cancer studies [R, et al, 2002] [J, et al, 2004]

Methodology
Weka Machine Learning workbench [I, et al, 2005] is used for all classification and regression algorithm
implementation. The algorithms used are ZeroR (numeric mode or majority class prediction), linear
regression (minimizes sum of squared errors between linear combination of attribute values and prediction
target) [H, 1974] [JL, 1995] and logistic regression [S, et al, 1992]. Data preprocessing methods used are
Minimum Description Length (MDL) discretization and correlation-based feature selection. MDL
discretization transforms numeric attributes into nominal attributes by binning the attribute values relative to
changes in the target classification, as measured by the minimum description length (MDL) principle [UM,
et al, 1993]. Correlation-based feature selection (CFS) heuristically selects a subset of attributes such that
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attributes in the subset exhibit high correlation to the target class and low correlation to each other [MA
2000]. Clinical prediction models are then generated using classification for nominal targets and regression
for numeric targets. Metrics of predictive performance are evaluated over 10 iterations of 10-fold crossvalidation with random re-seeding. Performance of classification models is evaluated via the mean
classification accuracy (percentage correct) across these 100 repetitions. Regression models are evaluated by
calculating r-squared values which define percentage of response variance accounted for by the prediction
model.

Result and Analysis
Classification performance of the data mining techniques apparently is equivalent or better than that of
conventional logistic regression. This distinction has a tendency to be most noteworthy over the original
data with no preprocessing. When preprocessing is connected as CFS feature selection and MDL attribute
discretization, logistic regression execution enhances extraordinarily. Performance of the data mining
methods also improves with preprocessing. However, in several experiments the accuracy difference
between typical data mining performance values and logistic regression performance is no longer large
enough to be statistically significant at the level p<0.05. The author has compared the performance of 1240
generated data mining predictive models against logistic regression. The overall classification performance
of the data mining methods is generally comparable or statistically superior to logistic regression.

Conclusion and Future Work
The present paper has described the application of machine learning models to data mining over a database
of cancer patient clinical performance with a view toward predicting specific outcomes, including patient
survival and quality of life. The data mining methods considered here delivered comparable or superior
predictive performance to that of traditional multivariate regression methods for nearly all prediction targets.
Future work should consider further advantages of data mining, particularly the expressiveness of the
resulting models and their potential usefulness to clinicians in understanding the factors that influence
disease state and in making clinical decisions. One technical gap to consider in future work is the trade-off
between smaller feature-rich data set, and other available data sets which provide larger numbers of patients
but comparatively less individual detail.

2.3 Prediction of pancreatic cancer survival through automated selection of predictive models:
Motivation
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The quality of the predictions produced by a given machine learning method varies across patients. In
particular, the method that provides the best predictive model for one patient will not necessarily be
optimal for another patient. The latter fact suggests that overall predictive performance across all
patients could be improved if it were possible to reliably predict, for each patient, what machine learning
method will provide the best performance for that particular patient. The selected method can then be
used to make predictions for the patient in question. This is the approach described in this paper.

Dataset
A clinical database containing retrospective records of 60 patients treated by resection for pancreatic
adenocarcinoma at the University Of Massachusetts Memorial Hospital in Worcester was created. Each
patient record is described by 190 fields comprising information about preliminary outlook, personal and
family medical history, diagnostic tests, tumor pathology, treatment course, surgical proceedings, and
length of survival. The attributes are divided into three major categories: 111 pre-operative attributes, 78
peri-operative attributes, and the target attribute. The prediction target (or target attribute) of this
analysis is survival time, measured as the number of months between diagnosis and death. All patients
considered in this study have known dates of death, hence the potential statistical issue of data censoring
that is, prematurely “cut oﬀ ” data, does not occur.
Experimental Protocol
Select Level 0 Classifiers: Each of the machine learning strategies is connected under thought with and
without highlight determination to the dataset and recorded the subsequent precision detailed by the 10
reiterations of 10-overlap cross approval technique is recorded. For each of the machine learning
systems, the majority of the element choice methodologies are tried with a changing number of ascribes
to be chosen. As a rule, highlight determination expanded the precision of the machine learning
strategies. At that point the main 3 most precise models among all models are chosen: the ones with and
the ones without highlight choice. Select the Level 1 Classifier: Once the main 3 performing level 0
models are distinguished, creator tentatively figured out what subset of those 3 beat models together
with what level 1 machine realizing method would yield the model-selector meta-classifier with the
most noteworthy prescient precision. As over, all machine learning strategies with and without highlight
choice (and permitting the extent of the chose credit set to shift) are considered for level 1 show
development. Take note of that for this situation, include determination is connected to the level 1
dataset, not to the first dataset. The model selector meta-classifier with the most noteworthy prescient
exactness is then revealed.
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Results and Analysis
The naıve Bayes (NB) classifier clearly benefits from attribute selection in this study: its classification
accuracy is higher when trained over a relatively small number of selected attributes. On the other hand,
the Bayes Network (BN) classifier performs best when allowed to operate over a larger set of attributes
that has undergone little or no selection. The different results in the two cases are explained by the fact
that the naıve Bayes technique, unlike Bayes Networks, is based on the assumption of conditional
independence among the non-class attributes given the class. Attribute selection extracts a smaller set of
less-correlated predictive attributes, thus bringing the attribute set closer to satisfying the conditional
independence assumption.

Table 1: Classification accuracy for nine-month survival dataset

This paper has presented a new approach to combining predictive methods through automated metalearning, and an evaluation of this technique for the prediction of pancreatic cancer survival using a
database of retrospective patient records. The experimental evaluation presented in this paper focuses on
predicting survival time of pancreatic cancer patients based on attributes such as demographic
information, initial symptoms, and diagnostic test results. Individual predictors considered include
various machine learning techniques as well as logistic regression. The evaluation results show that the
proposed technique of model selection meta-learning produces predictions that are better than those of
the individual predictive methods. Also, the proposed technique outperforms the standard meta-learning
techniques of bagging, boosting, and stacking in the experiments conducted for this paper.
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2.4 Data Mining Techniques for Prognosis in Pancreatic Cancer:
Approach
Goal of this paper [Floyd, et al., 2007] is to predict expected survival time of the patient. Instead of
comparing the accuracies of models constructed using Machine Learning algorithms, this paper says that
since the collaborators know the patients in the dataset, asking them to predict a patient's survival given a set
of attributes from this dataset would likely not be representative of their ability to predict the expected
survival of a new patient. Therefore, Logistic Regression and ZeroR are used as benchmark algorithms.Gain
Ratio, Principal Components, ReliefF, and Support Vector Machines are used for feature selection. These
algorithms rank the most important features so are run several times, varying the condition on the number of
features to return. This method is used to determine the optimal feature for a given machine learning
algorithm. Baseline algorithms are compared with several other machine learning algorithms, including
artificial neural networks, Bayesian networks, decision trees, naïve Bayes networks, and support vector
machines. For each dataset, the best combination of feature selection and machine learning algorithm is
identified. These combinations are compared with ZeroR and logistic regression. An attempt is made to
improve the classification accuracy by experimenting with both bagging, boosting, stacking, and model
selector described in the paper. The primary focus in this study is on improving the classification accuracy
by combining multiple machine learning models generated by the best pairs of feature selection and machine
learning algorithm.
The classification accuracy for all experiments is calculated by running ten repetitions, each repetition
with a different initial random seed, of tenfold cross validation. The models with the highest
classification accuracy are then selected for further comparison. The classification accuracy of these
models is compared to the classification accuracy of a model built using logistic regression. Once the
best combinations of feature selection and machine learning algorithm is found, Bagging is evaluated
on each of these combinations as a method to reduce the standard deviation of the classification
accuracy, as decreasing the standard derivation may increase the statistical significance. Boosting is
evaluated to increase the classification accuracy of each combination.

Results
The highest classification accuracy obtained by constructing models with no feature selection is
47.5%. There is an overall increase in the classification accuracies as the number of attributes is
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increased from 10 to 30. When 30 attributes are selected there are several models with
classification accuracies above 47.5% including ones constructed using artificial neural networks
with one hidden unit, artificial neural networks with two hidden units, Bayesian networks with one
parent, and logistic regression. After this peak at 30 attributes most models show a gradual decrease
in classification accuracy as the number of attributes selected increases. The classification accuracy
of this model continues to increase until it peaks when 60 attributes are selected. The best model
with no feature selection resulted from a model constructed using a Bayesian network with a
maximum of two parents.

2.5 Premalignant Pancreatic Cancer Diagnosis Using Proteomic Pattern Analysis:
Approach
The goal of this paper [Htike, et al., 2015] is to predict, given a mass spectrum derived from a serum
sample, whether or not the sample comes from a patient with early pancreatic cancer. Two steps are
performed in pre-processing: base-line correction and smoothing. Base-line correction is done because a
major of the m/z ratios have non-zero intensity values or spurious peaks because of systematic error,
background noise, and chemical noise. Therefore, the true mass spectrum without the contaminants is
estimated. A ‘top-hat’ filter to perform baseline correction is proposed. It entails subtracting the
observed spectrum its morphological opening. Spectrum smoothing is then performed next in order to
alleviate very high frequency components [Coombes, et al, 2005]. A wavelet noise removal technique is
also proposed. It entails dividing the mass spectrum into components of different scales and estimating
the wavelet coefficients [Alpaydin, 2010]. Coefficients corresponding to high frequency components are
then discarded in order to smoothen the spectrum.

Feature Extraction and Classification
RELIEF is used as a Feature Selection algorithm. It is used select 300 best m/z ratios that best
discriminate pancreatic cancer. A proteomic mass spectrum is now represented by a 300-dimensional
feature vector [Kononenko, et al, 1997]. A hybrid technique called a logistic model tree [Landwehr, et
al, 2005] to classify 300-dimensional feature vector is used. The proposed logistic model tree applies
LogitBoost with simple regression functions as base learners in order to fit the logistic models.
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Experiments
Dataset from University of Pennsylvania is used [Hingorani, et al, 2003]. Dataset contains 181 serum
samples where 80 samples are pancreatic intraepithelial neoplasia samples and the remaining 101
samples are healthy or control samples. The mass spectrum of each serum sample contains 6771 m/z
ratios that range from 800 to 11992.91. Leave-one-out cross-validation is used where one sample was
held out as the validation data while the remaining samples served as training data. The whole process
was repeated multiple times such that each sample got held out exactly once as the validation data. The
results were then averaged to produce an estimator to the accuracy of the proposed pancreatic cancer
diagnosis system. Throughout all the experiments, minimum number of boosting iterations of 50, the
maximum number of boosting iterations of 1500, and the heuristic threshold value of 60 as parameters
of the logistic model tree were used. Table 2 lists the summary of the leave-one-out cross-validation
results.

Table 2: LOOCV Results Summary

134 out of 181 samples are predicted accurately giving an accuracy of 75 %. Cohen coefficient value is
0.47. Root Mean Square Error is found to be 0.4470 which is quite less. Table 4 displays the results. The
true positive rate of the disease class is lower than that of the control class. Moreover, the false positive
rate for the tumor class is likewise lower than that of the control class. This implies the framework
creates more negative forecasts than positive expectations. As per the author, this maybe because of the
imbalanced class distribution.

Page 18 of 42

Table 3: Detailed Results by Output Class

Conclusion
Given the mass spectrum of a serum sample, the system predicts whether the serum shows signs of
premalignant pancreatic cancer. This system has achieved an accuracy of 74.0331% in early
premalignant pancreatic cancer detection for this dataset. The accuracy is not that high because this is a
very challenging problem owing to the fact that in the early stages of cancer, there are only miniscule
differences in the proteomes. However, the preliminary experimental results are quite promising. As
future work, the author mentions that he will perform optimization of the system parameters to further
boost the performance of the system. He would also like to test this framework on a wide range of other
types of cancer.

2.6 Combining PubMed knowledge and EHR data to develop a weighted Bayesian network for
pancreatic cancer prediction
Approach
In this paper [Zhao, et al., 2011], PubMed knowledge and Electronic Health Records is combined
to develop a weighted Bayesian Network Inference model for pancreatic cancer prediction. 20
variables that are used to design the BNI models are: age, alcohol or cigarette abuse, abdominal
pain, fatigue or asthenia, nausea, vomiting, weight loss, depression, appetite loss, diabetes mellitus,
jaundice, carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), gamma-glutamyl
transferase (GGT), glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST),
alkaline phosphatase (ALP), albumin and bilirubin. Learning from rule based method designed by
Chen et al. to calculate associations among biological terms [H, et al, 2004], Keyword-based
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method was used to automatically extract and classify PubMed abstracts that mentioned both any of
the risk factors and pancreatic cancer together to calculate the weight of each risk factor. Each
PubMed abstract was classified into one of the following three categories according to the
association between the selected variable and pancreatic cancer: positive, negative, or neutral
association. To ensure high accuracy in the abstract classification phase, the machine classification
results were further reviewed manually and corrected as appropriate, although the manual review
was greatly enhanced by the text-mining algorithm since the sentences containing the keywords
were automatically highlighted to ease the manual review. For each risk factor, only the abstracts
containing positive and negative associations between the risk factor and pancreatic cancer were
used to calculate the original weights for each risk factor. Each risk factor is treated as a binary
variable without considering the severity, degree, accumulative length, or other quantitative
information of the risk factor. The value “true” represents the presence of a factor and the value
“false” represents the absence of a risk factor.
Results and Discussion
The top three variables associated with pancreatic cancer, ranked by importance, were: weight loss,
abnormal glucose, and abnormal CA 19-9. In contrast to the PubMed weighting results, the top three
most frequent variables appearing in pancreatic cancer patients EHR were: glucose, albumin, and
nausea. Accuracy indicated by weighted BNI (91%) is significantly higher than conventional BNI
(80.6%), KNN (71.8%) and SVM (72.7%). As shown in Figure 2, ROC curve of the weighted BNI is
higher than that of the conventional BNI, KNN and SVM, indicating a better performance is achieved
by the weighted BNI for pancreatic cancer prediction.

Figure 1: Comparison of ROC curves of the weighted BNI, the conventional BNI, KNN and SVM
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3. RESEARCH HYPOTHESIS AND OBJECTIVES
Research Objective:
Given the technical gaps discussed previously, the work reported here begins to bridge this gap by
utilizing extra components: family history, acquired hereditary disorders, endless pancreatitis, cirrhosis
of the liver, stomach issues, abstain from food, physical dormancy, caffeine intake alongside existing
elements. For example, age, liquor or cigarette use, stomach agony, weariness or asthenia, weight
reduction, diabetes mellitus, jaundice, sugar antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA),
gamma-glutamyl

transferase

(GGT),

glucose,

alanine

aminotransferase

(ALT),

aspartate

aminotransferase (AST), basic phosphatase (ALP), HGVSp_Short, cDNA_position, CDS_position,
ENSP, UNIPARC, EXON to make clinical and genomic dataset comprising of subset of these elements.
Then use Support Vector Machine classifier on these datasets first individually and later by combining
both the datasets to make predictions about pancreatic cancer. Based on the technical Gap, Null and
Alternate Hypothesis are stated below

Alternate Hypothesis:
Support Vector Machine as a classification algorithm will improve prediction accuracy of pancreatic
cancer model by approximately 5% if combination of subset of features mentioned above in the research
objective is used.

Null Hypothesis:
Support Vector Machine as a classification algorithm will not improve prediction accuracy of pancreatic
cancer by 5% if combination of subset of features mentioned above in the research objective is used.
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4. EXPERIMENTAL DESIGN
The experiments defined below are intended to test the hypothesis posited above. All experiments will

measure the effect of carrying out the experiments by employing the metrics described below.
1. Calculate accuracy of Pancreatic Cancer Prediction Model on Clinical Dataset
2. Calculate accuracy of Pancreatic Cancer Prediction Model on Genomic Dataset
3. Create Synthetic dataset of Clinical features
4. Derive features using various combinations of features in Synthetic Clinical dataset
5. Derive features using various combinations of features in Genomic dataset
6. Make Predictions on the combination of Synthetic Clinical and Genomic datasets

5. APPROACH AND METHOD
For conducting the experiments, four real datasets and one synthetic dataset are used.

5.1. QCMG Data Set
This data is obtained from “cbioportal”. Data set consists of both clinical as well as genomic
data. It has 383 clinical samples. Mutation data file consists of 22763 samples and 115 features per
sample. There are two separate files for clinical and genomic data each. Clinical data consists of
features like patient_id, ethnicity, sex, age, smoker, country, etc. Genomic data file consists of
features like Gene_Id, Chromosome, Variant_type, start_position, end_position, reference_allele,
etc.
In the dataset, 60 features from 115 features consisted of more than 50% missing values so these
features are removed. Also removed missing values for remaining features in the dataset. After
processing, the dataset size is 8994 x 53.
Visualized combination of various features using heat map in order to identify important features
related to the dependent variable i.e. pancreatic cancer. Following heat map shows the correlation
between various features. As it can be seen from the heat maps that none of the features are
strongly correlated to the dependent variable i.e. STATUS
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Figure 2: Heat Map of features
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Figure 3: Heat Map of features
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Figure 4: Heat Map of features
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Figure 5: Heat Map of features

5.2. TCGA Data Set
This dataset is obtained from “cbioportal”. Dataset consists of separate files for mutation and
clinical data. Clinical data has 184 samples with 23 features for each sample. Clinical dataset has
features like Gender, Race, Ethnicity, Alcohol_History, Diabetes, Family_History_of_Cancer.
Genomic dataset consisted of similar features as mentioned above in QCMG data.
The dataset did not contain any missing values. Before visualizing the data, converted the
categorical features to numeric using LabelEncoder. Visualized clinical data using heat map as
shown below. It can be seen from the heat map that none of the features is strongly correlated with
the dependent variable which in this case is ‘VITAL_STATUS’.
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Figure 6: TCGA dataset features Heat Map
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5.3. PLCO Data Set
This dataset is obtained from NCI Cancer Data Access System. It is a clinical dataset
of 1,54,897 patients and 154 features per patient. Features consists of age, sex, panc_cancer,
marital, cigarette_status, family_cancer_history, diabetes, liver_comorbity, etc.
The important features that are identified from list of 154 features based on the hypothesis are
Age, Participant's current cigarette smoking status, The total number of years the participant
smoked, # of Cigarettes Smoked Per Day, Age Started Smoking, Has Family History of
Any Cancer, Family History of Pancreatic Cancer, Diabetes, Liver Comorbidities, Age
stopped smoking, Drink Alcohol, Caffeine, Glucose. Removed missing values for all the
above mentioned features. Visualized the data using heatmaps to find out correlation
between these features and dependent variable. Also plotted scatter plots to find relationship
between variables. After carefully looking at the data, it is observed that the dataset is highly
imbalanced. 98 % records belong to class 0 (Non Cancer) and 2 % belong to class 1
(Cancer).
Plotted the data on a scatter plot to identify relationship between variables. As
shown in the scatter plot below, the relationship between variables is not linear.
Heat map is used in order to identify important variables related to dependent variable i.e.
Pancreatic Cancer status. It can be inferred from the heat map below that none of the
variables is highly correlated to the dependent variable.
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Figure 7: PLCO dataset features Heat Map
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Figure 8: TCGA dataset Correlation Matrix
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5. APPROACH AND METHOD
5.4. Clinical Synthetic Data:
Since none of the datasets mentioned above helped in predicting Pancreatic Cancer, Synthetic
dataset of clinical features is created as mentioned below:
o Unexpected Weight Loss: 1 – No, 2 – Moderate, 3 – Significant
o Smoking: 0 – Non smoker, 1 – Light, 2 – Heavy
o Jaundice: 0 – No, 1 – Yes
o Floating Bowels: 0 – No, 1 – Yes
o Itchy Skin: 0 – No, 1 – Moderate, 2 – High
o Blood clot in leg: 0 – No, 1 – Small, 2 – Big
o Liver Enlargement: 0 – No, 1 – Yes
These are strong clinical symptoms of Pancreatic Cancer. Since pancreatic cancer is
hard to detect, any one symptom is not a very strong indicator of cancer. Hence various
combinations

of

these

features

along

with

their

individual

contribution are considered. 90 % of data belongs to class 0 (Non pancreatic Cancer) and 10 %
data belongs to class 1 (Pancreatic Cancer).
Data

is

visualized

using

heatmap

in

order

to

obtain

importance

of

individual

features and their combination. As it can be seen from the heatmap that the combination
of features is strongly correlated to the dependent variable i.e. cancer than any
individual feature.
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Figure 9: Synthetic dataset features Heat Map

Various features are derived as
example
‘Smoking’.

a combination of above mentioned features. For

‘Combination_Wieght_Smoking’
Other

derived

‘Combination_Smoking_Jaundice’,

is

a

combined

features

are

feature

of

‘Weight’

and

‘Combination_Weight_Jaundice’,

‘Smoking_Weight_Jaundice_Bowels’,

etc.

The

values

for any combined feature is calculated by taking mean of the individual features. And the
pancreatic cancer value is assigned to a particular record based on whether majority of its
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predictor variables values are in favor of pancreatic cancer or not. In all the shape of the
dataset is 400 x 16 i.e. 400 samples with 16 variables for each sample.
Support

Vector

Machine

Binary

Classifier

is

used

to

make

predictions.

Before

building the model, the dataset was split into Training data (70 %) and Testing data (30 %).
The predictor variables and dependent variable are separated in training and testing data.
Support Vector Machine ‘Linear’ kernel is used for building the model. The model is
trained on 70 % training data and validated on remaining 30 % data. The model has been
evaluated on metrics like accuracy, precision, recall and area under curve (auc) score.

6. RESULTS
Experiments with multiple datasets are conducted as mentioned in the above section and below are the
results with each one of them.

6.1 PLCO Dataset Results
Since this dataset is highly imbalanced i.e. only 0.47 % belongs to class 1 (Pancreatic Cancer),
following approaches are considered:

Subset of features:
Since the dataset consisted of 154 features, various subsets of features are considered. Since
abnormal weight loss is a prominent symptom of cancer, feature ‘weight difference’ is derived using
‘weight_at_20’ and ‘weight_at_50’ features. Support Vector Machine Classifier is used to make
predictions and result is as follows

Metric
Precision
Recall
Accuracy
AUC
Score

Class 0
Class 1
Class 0
Class 1

Value
0.99
0
1
0

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

99.52%

Ratio of correct predictions to total predictions

0.5

Area Under Reciever Operating Characteristic Curve

Table 4: PLCO Data Results for Subset of Features
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Since this feature is not correlated with Pancreatic Cancer, the results are not good. The
accuracy is so high because the data set is highly imbalanced and it classifies almost every
sample as class 0.
Smoking is another prominent symptom for pancreatic cancer. The dataset contained features
like ‘no. of years smoked’ and ‘no. of cigarettes smoked per day’. Using these a new feature
‘total cigarette smoked’ is derived and have made predictions using it. There is no correlation at all
between

this

feature

and

the

dependent

variable.

Couple

of

other

features

like

‘family_history_cancer’, ‘liver_comorbidity’ along with ‘total cigarette smoked’ are also considered
and following are the results of SVM classifier:

Metric
Precision
Recall

Class 0
Class 1
Class 0
Class 1

Accuracy
AUC
Score

Value
0.99
0
1
0

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

99.54%

Ratio of correct predictions to total predictions

0.5

Area Under Reciever Operating Characteristic Curve

Table 5: PLCO Data Results for Subset of Features
Dataset is balanced by undersampling the majority class features. The new dataset
consists of 692 class 0 and 692 class 1 samples. Support Vector Machine classifier results
are as follows:

Metric
Precision
Recall
Accuracy
AUC
Score

Class 0
Class 1
Class 0
Class 1

Value
0.55
0.58
0.51
0.62

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

56.73%

Ratio of correct predictions to total predictions

0.56

Area Under Reciever Operating Characteristic Curve

Table 6: PLCO Data Results with Undersampling
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In this case, the accuracy is less since the dataset consists of equal number of class 0 and class
1 samples. However the Precision and Recall values have improved as the probability of the
classifier predicting the correct class for each sample is high.
Top correlating features with the dependent variable are: 'HGVSp_Short' ,'cDNA_position',
CDS_position', 'ENSP', 'UNIPARC', 'EXON'. This subset of features is used to build a
SVM model and make predictions. Results are as follows:

Metric
Precision
Recall

Class 0
Class 1
Class 0
Class 1

Accuracy
AUC
Score

Value
0.81
0.2
0.99
0

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

80.77%

Ratio of correct predictions to total predictions

0.5

Area Under Reciever Operating Characteristic Curve

Table 7: Results with Genomic Data

Weighted Classification:
Since the dataset is highly imbalanced, have assigned weights to the minority class samples
i.e. class 1. This is achieved in Support Vector Machines by using the parameter
‘class_weight = balanced’. This replicates the smaller class until there are as many samples as
in the larger one but in an implicit way. Results for this are as follows:

Metric
Precision
Recall
Accuracy
AUC
Score

Class 0
Class 1
Class 0
Class 1

Value
0.99
0.01
0.58
0.54

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

58.04%

Ratio of correct predictions to total predictions

0.56

Area Under Reciever Operating Characteristic Curve

Table 8: Results with Weighted Classification
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6.2 Synthetic Clinical Data Results
This dataset consists of 400 samples and 16 features. It has 10 % data for class 1 i.e. having cancer
and 90 % data for class 0 i.e. not having cancer. Have applied support vector machine classification
and following are the results along with ROC plot for synthetic clinical data results:

Metric
Precision
Recall
Accuracy
AUC
Score

Class 0
Class 1
Class 0
Class 1

Value
0.93
1
1
0.33

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

93.33%

Ratio of correct predictions to total predictions

0.67

Area Under Reciever Operating Characteristic Curve

Table 9: Results with Synthetic Clinical Data

Figure 10: Receiver Operating Characteristic Curve for Synthetic Clinical Data
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6.3 Real Genomic and Clinical Synthetic Data Results
Genomic data from QCMG and Synthetic Clinical data are combined. Features used from Genomic data
are: 'HGVSp_Short', 'cDNA_position', 'CDS_position', 'ENSP', 'UNIPARC', 'EXON'. A prediction model
is built using Support Vector Machines Classifier and following are the results:

Metric
Precision
Recall

Class 0
Class 1
Class 0
Class 1

Accuracy
AUC
Score

Value
0.91
0
1
0

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

90.83%

Ratio of correct predictions to total predictions

0.5

Area Under Reciever Operating Characteristic Curve

Table 10: Clinical Data and only Individual Genomic features

Metric
Precision
Recall
Accuracy
AUC
Score

Class 0
Class 1
Class 0
Class 1

Value
0.89
0
1
0

Explanation
Given a class 0 prediction from the classifier, how likely is it to be correct
Given a class 1 prediction from the classifier, how likely is it to be correct
Given a class 0 sample, how likely will the classifier detect it
Given a class 1 sample, how likely will the classifier detect it

89.16%

Ratio of correct predictions to total predictions

0.5

Area Under Reciever Operating Characteristic Curve

Table 11: Clinical Data and (Individual + Derived) Genomic features

Page 37 of 42

7. DISCUSSION
From the results, it can be seen that it is important to have relevant features in order to predict Pancreatic
Cancer. Also, no individual feature is a strong symptom of pancreatic cancer and we need a combination
of features to make predictions. In the Synthetic data experiments, individual features like Jaundice,
Weight Loss, etc. are not strongly correlated with the dependent variable. Hence one cannot make
predictions based only on these variables. However a combination of these features like combination of
Jaundice and Smoking, Combination of Smoking and Weight Loss, etc. is more strongly correlated to
pancreatic cancer than individual features. As we combine more number of features, it is observed that
the correlation increases. Thus we can say that a combination of more number of clinical features is a
good predictor of Pancreatic Cancer than individual features.
The mutation data used in this work is not a good predictor of Pancreatic Cancer since none of the
features is correlated to the dependent variable. Even when the weakly correlated genomic data is
combined with strongly correlated synthetic clinical data, the results are not good. Thus it is necessary to
have a good dataset of genomic features so that a combination of genomic and clinical data might have
better prediction accuracy.

8. CONCLUSION AND FUTURE WORK
For Synthetic Clinical data, prediction results are good when a combination of features is used. For
genomic data, the prediction results are not good since it is very weakly correlated to the dependent
variable. Moreover the results degrade when synthetic clinical and real genomic features are combined
together. Thus in the real world if a good combination of clinical and genomic features is considered
then Pancreatic Cancer can be predicted accurately. However, based on the results obtained in this study,
the Hypothesis that “Combination of Clinical and Genomic features will improve the prediction
accuracy of Pancreatic Cancer by 5 %” is refuted.
In the future, plan to collect and conduct experiments on more significant real world genomic data. Also
plan to incorporate additional clinical features to build a better model. Future work will also include
calculating p-value to determine statistical significance in a hypothesis test. p-value will evaluate how
well the sample data support that the null hypothesis is true. A high p-value suggests that the sample
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data provides enough evidence to accept null hypothesis for the entire population while a low p-value
suggests evidence to reject null hypothesis.

9. PROJECT SCHEDULE
Complete project implementation took around 3-4 months. Inside this time allotment every one of the
tasks specified in the strategy and approach area of the report were completed. A fundamental Pancreatic
Cancer Prediction model was produced using Support Vector Machines before fifth week. Before 10
weeks' over every one of the tasks mentioned in the design of experiments were finished. Remaining
time was spent for composing the report. A more point by point timetable is described in the table
below.

EXPERIMENTS

WEEK

DATA SET EXPLORATION

0-1

LOADING DATA SET AND MORE EXPLORATION

1-2

DATA PREPROCESSING AND FEATURE

3-4

ENGINEERING
APPLYING SVM ON THIS MODEL

4-5

FINE TUNING SVM PARAMETERS

5-6

OTHER DATA SETS EXPLORATION

6-7

MORE DATA PROCESSING AND EXPERIMENTS

7-9

WITH MULTIPLE DATASETS
CREATING SYNTHETIC DATA AND BUILDING
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9-10

MODEL
PROJECT REPORT

10-12

REFERENCES
[1] Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J
Clin. 2009;59:225–49. [PubMed]
[2] Shariat, Shahrokh F., et al. "Critical review of prostate cancer predictive tools." Future oncology 5.10
(2009): 1555-1584.
[3] e.Siegel RL, "Cancer statistics, 2016. - PubMed - NCBI", Ncbi.nlm.nih.gov, 2017. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/26742998. [Accessed: 22- Jan- 2017].
[4] e. Torre LA, "Global cancer statistics, 2012. - PubMed - NCBI", Ncbi.nlm.nih.gov, 2017. [Online].
Available: https://www.ncbi.nlm.nih.gov/pubmed/25651787. [Accessed: 22- Jan- 2017].
[5] --Lowenfels AB, Maisonneuve P: Epidemiology and prevention of pancreatic cancer. Jpn J Clin
Oncol 2004, 34: 238–244. 10.1093/jjco/hyh045
[6] Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet 2004, 363: 1049–1057.
10.1016/S0140-6736(04)15841-8
[7] Jafari M, Abbruzzese JL: Pancreatic cancer: future outlook, promising trials, newer systemic agents, and
strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force. Surg Oncol Clin N
Am 2004, 13: 751–60, xi. 10.1016/j.soc.2004.06.009
[8] --Chung CK, Zaino RJ, Stryker JA. Colorectal carcinoma: evaluation of histologic grade and factors
influencing prognosis. J Surg Oncol. 1982; 21: 143-148.
[9] --Berti Riboli E, Secco GB, Lapertosa G, Di Somma C, Santi F, Percivale PL. Colorectal cancer:
relationship of histologic grading to disease prognosis. Tumori. 1983; 69: 581-584.

Page 40 of 42

[10]Fujino Y, Suzuki Y. Predicting factors for survival of patients with
pancreatic cancer: a management guideline. Hepatogastroenterology 2003;49:250–3.

unresectable

[11]Strnad R, Ryska M. Are we able to predict survival rate after the radical resection of the
pancreas for the pancreatic ductal adenocarcinoma?In: Joint meeting of the European
Pancreatic Club (EPC) and the International Association of Pancreatology (IAP); 2002.
[12]Tseng
JF.
Resection
of
the
superior
mesenteric-portal
vein
for
pancreatic
adenocarcinoma: Margin status and survival duration. In: 45th annual meeting of the
Society for Surgery of the Alimentary Tract; 2004.

[13]Kukar M, Besic N, Kononenko I, Auersperg M, Robnik-Sikonia M. Prognosing the survival time of
patients with anaplastic thyroid carcinoma with machine learning. In: Zupan B, Keravnou E, Lavrac N,
editors. Intelligent data analysis in medicine and pharmacology. Dordrecht, The Netherlands: Kluwer
cademic Publishers; 1997. p. 116–29.
[14]Witten I, Frank E. Data mining: practical machine learning tools and techniques, 2nd ed, San Francisco,
CA, USA: Morgan Kaufmann; 2005.
[15]Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control
1974;19(December (6)):716–23.
[16]Devore JL. Probability and statistics for engineering and the sciences, 4th ed., Belmont, CA, USA:
Brooks/Cole Publishing Company; 1995.
[17]le Cessie S, van Houwelingen JC. Ridge estimators in logistic regression. Applied Statistics
1992;41(1):191–201.
[18]Fayyad UM, Irani KB. Multi-interval discretization of continuous-valued attributes for classification
learning. In: Bajcsy R, editor. Proc. 13th Intl. Joint Conf. on Artificial Intelligence (IJCAI-1993), vol. 2.
San Mateo, CA, USA: Morgan Kaufmann; 1993. p. 1022–9.
[19]Hall MA. Correlation-based feature selection for discrete and numeric class machine learning. In:
Langley P, editor. Proc. 17th international conf. on machine learning. 2000.p. 359–66.
[20]DeWitt J, Devereaux B. Comparison of endoscopic ultrasonography and multidetector computed
tomography for detecting and staging pancreatic cancer. Annals of Internal Medicine
2004;141(November (10)):753–63.
[21]Chen H H, Sharp B. Content-rich biological network constructed by mining PubMed abstracts. BMC
Bioinform 2004;5(1):147.
[22]cid
_prod,
"What
is
pancreatic
cancer?,"
2017.
[Online].
Available:
http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-what-is-pancreatic-

Page 41 of 42

cancer. Accessed: Jan. 14, 201Qiu, Yushan, et al. "Towards prediction of pancreatic cancer using SVM
study model." Journal of Clinical Oncology and Research (2014).
[23]"Pancreatic
Cancer
Risk
Factors",
Cancer.org,
2017.
[Online].
http://www.cancer.org/cancer/pancreatic-cancer/causes-risks-prevention/risk-factors.html.
22- Jan- 2017].

Available:
[Accessed:

[24]Qiu, Yushan, et al. "Towards prediction of pancreatic cancer using SVM study model." Journal of
Clinical Oncology and Research (2014).
[25]Hayward, John, et al. "Machine learning of clinical performance in a pancreatic cancer database."
Artificial Intelligence in Medicine 49.3 (2010): 187-195.
[26]Floyd, Stuart, et al. "Prediction of Pancreatic Cancer Survival through Automated Selection of
Predictive Models." International Joint Conference on Biomedical Engineering Systems and
Technologies. Springer Berlin Heidelberg, 2010.
[27]Floyd, Stuart. Data Mining Techniques for Prognosis in Pancreatic Cancer. Diss. Boston College, 2007.
[28]Htike, Zaw Zaw, and Shoon Lei Win. "Premalignant Pancreatic Cancer Diagnosis Using
Proteomic Pattern Analysis." Journal of Medical and Bioengineering Vol 4.4 (2015).
[29]Leonard Wesley et al. American Journal of Biochemistry and Biotechnology 2016, DOI:
10.3844/ajbbsp.2016
[30]Zhao, Di, and Chunhua Weng. "Combining PubMed knowledge and EHR data
to develop a weighted bayesian network for pancreatic cancer prediction."
Journal of biomedical informatics 44.5 (2011): 859-868.

Page 42 of 42

